Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancerSasagu Kurozumi,Andrew R. Green,Ian O. Ellis,Emad A. Rakha,Takaaki Fujii,Ken Shirabe,David Heery,Wilbert Zwart,Steffi Oesterreich,Simon J. JohnstonCANCER RESEARCH(2020)引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要